Inactive Instrument
NicOx SA Stock Euronext Paris
Stocks
NCOX
FR0000074130
Pharmaceuticals
OTC Markets Traded| Market Cap | 33.93M 39.3M 31.83M 28.99M 54.52M 3.76B 55.27M 373M 146M 1.88B 148M 144M 6.26B | P/E 2026 * |
-5.5x | P/E 2027 * | 38.5x |
|---|---|---|---|---|---|
| Enterprise Value | 33.93M 39.3M 31.83M 28.99M 54.52M 3.76B 55.27M 373M 146M 1.88B 148M 144M 6.26B | EV / Sales 2026 * |
11.3x | EV / Sales 2027 * | 3.39x |
| Free-Float |
99.65% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -7.95% |
| Manager | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
CEO | Chief Executive Officer | 55 | 28/02/2024 |
Sandrine Gestin
DFI | Director of Finance/CFO | 58 | 01/01/2015 |
Doug Hubatsch
CTO | Chief Tech/Sci/R&D Officer | - | 13/12/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
BRD | Director/Board Member | 55 | 08/04/2024 |
Damian Marron
CHM | Chairman | 64 | 16/07/2024 |
Marc Bozec
BRD | Director/Board Member | - | 16/07/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.95% | -9.39% | - | - | 39.28M | |
| -0.09% | +3.60% | +61.04% | +24.52% | 335B | |
| +0.07% | -4.95% | +23.16% | -14.86% | 68.61B | |
| +4.82% | +0.94% | +50.20% | +143.83% | 11.2B | |
| -1.47% | -0.20% | -3.48% | -4.26% | 8.49B | |
| -0.34% | +2.22% | -13.22% | -7.03% | 4.84B | |
| +1.45% | +3.85% | -26.84% | +18.44% | 4.42B | |
| +1.40% | -0.80% | +2.23% | +47.88% | 4.28B | |
| -0.32% | +2.12% | +11.82% | +59.07% | 2.81B | |
| -0.60% | -3.43% | -5.51% | -3.09% | 2.19B | |
| Average | -0.35% | -0.30% | +11.05% | +29.39% | 49.11B | |
| Weighted average by Cap. | -0.05% | +3.42% | +50.74% | +20.78% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3M 3.48M 2.81M 2.56M 4.82M 332M 4.89M 32.99M 12.93M 166M 13.05M 12.76M 554M | 10M 11.58M 9.38M 8.54M 16.07M 1.11B 16.29M 110M 43.1M 555M 43.49M 42.55M 1.85B |
| Net income | -6M -6.95M -5.63M -5.13M -9.64M -665M -9.77M -65.99M -25.86M -333M -26.09M -25.53M -1.11B | 1M 1.16M 938K 854K 1.61M 111M 1.63M 11M 4.31M 55.49M 4.35M 4.25M 185M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
